Чланци са овлашћеним јавним приступом - Eugeen VanmechelenСазнајте више
УкупноSwedish Research CouncilEuropean CommissionMRCFWONIHZonMwINSERMGovernment of SpainKnut and Alice Wallenberg FoundationANRCIHRAXA Research Fund, FranceFRQSRCNBanking Foundation "la Caixa"Academy of FinlandMarianne and Marcus Wallenberg FoundationSNSFNHMRCNSERCFCTAlzheimers's UKNIHRBMBFGovernment of ItalyDoDNSFCDFGDSFNWOFormasParkinson's UKFNRInnovation Fund DenmarkNKFIRoyal Society UK
Није доступно нигде: 2
Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples
E Pérez-Ruiz, D Decrop, K Ven, L Tripodi, K Leirs, J Rosseels, ...
Analytica chimica acta 1015, 74-81, 2018
Овлашћења: Research Foundation (Flanders)
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
NG de San José, J Goossens, MR Al Shweiki, S Halbgebauer, P Oeckl, ...
Journal of psychiatric research 156, 390-397, 2022
Овлашћења: European Commission, Federal Ministry of Education and Research, Germany
Доступно негде: 83
The β-secretase BACE1 in Alzheimer’s disease
H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ...
Biological psychiatry 89 (8), 745-756, 2021
Овлашћења: US National Institutes of Health, UK Medical Research Council, Parkinson's …
A practical guide to immunoassay method validation
U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ...
Frontiers in neurology 6, 179, 2015
Овлашћења: Research Foundation (Flanders), Swedish Research Council, Netherlands …
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ...
Archives of neurology 67 (8), 949-956, 2010
Овлашћења: US National Institutes of Health
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
NJ Ashton, TA Pascoal, TK Karikari, AL Benedet, J Lantero-Rodriguez, ...
Acta neuropathologica 141, 709-724, 2021
Овлашћења: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ...
Archives of neurology 69 (11), 1445-1452, 2012
Овлашћења: Swedish Research Council
Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
O Hansson, H Zetterberg, E Vanmechelen, H Vanderstichele, ...
Neurobiology of aging 31 (3), 357-367, 2010
Овлашћења: Swedish Research Council
Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
N Sergeant, A Bretteville, M Hamdane, ML Caillet-Boudin, P Grognet, ...
Expert review of proteomics 5 (2), 207-224, 2008
Овлашћења: National Institute of Health and Medical Research, France
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
Овлашћења: Research Foundation (Flanders)
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
M Milà-Alomà, NJ Ashton, M Shekari, G Salvadó, P Ortiz-Romero, ...
Nature medicine 28 (9), 1797-1801, 2022
Овлашћења: US National Institutes of Health, Banking Foundation "la Caixa", Academy of …
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
S Engelborghs, K De Vreese, T Van de Casteele, H Vanderstichele, ...
Neurobiology of aging 29 (8), 1143-1159, 2008
Овлашћења: Research Foundation (Flanders)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ …
M Suárez‐Calvet, TK Karikari, NJ Ashton, J Lantero Rodriguez, ...
EMBO molecular medicine 12 (12), e12921, 2020
Овлашћења: Banking Foundation "la Caixa", Swedish Research Council for Environment …
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
S Janelidze, D Bali, NJ Ashton, NR Barthélemy, J Vanbrabant, E Stoops, ...
Brain 146 (4), 1592-1601, 2023
Овлашћења: US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
NJ Ashton, S Janelidze, N Mattsson-Carlgren, AP Binette, O Strandberg, ...
Nature medicine 28 (12), 2555-2562, 2022
Овлашћења: US National Institutes of Health, Knut and Alice Wallenberg Foundation …
Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology
NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonaitis, ...
JAMA neurology 81 (3), 255-263, 2024
Овлашћења: US National Institutes of Health, Swedish Research Council, UK Medical …
Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes
MM Mielke, RD Frank, JL Dage, A Jeromin, NJ Ashton, K Blennow, ...
JAMA neurology 78 (9), 1108-1117, 2021
Овлашћења: US National Institutes of Health, Swedish Research Council, UK Medical …
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease
A Vergallo, L Megret, S Lista, E Cavedo, H Zetterberg, K Blennow, ...
Alzheimer's & Dementia 15 (6), 764-775, 2019
Овлашћења: Research Foundation (Flanders), National Institute of Health and Medical …
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years
J Hertze, L Minthon, H Zetterberg, E Vanmechelen, K Blennow, ...
Journal of Alzheimer's Disease 21 (4), 1119-1128, 2010
Овлашћења: Swedish Research Council
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
P Chatterjee, S Pedrini, NJ Ashton, M Tegg, K Goozee, AK Singh, ...
Alzheimer's & Dementia 18 (6), 1141-1154, 2022
Овлашћења: US National Institutes of Health, National Health and Medical Research …
Публикације и информације о финансирању аутоматски одређује рачунарски програм